Close
Patheon
Infographic - A Tale of Two Molecules
Product Development
Tuesday, May 17, 2016

What’s the best path for your low soluble molecule? Two molecules, both designed to treat the same condition, both with solubility challenges. Two biopharma companies racing to be first. Biopharma A chooses to move into trials as quickly as possible, while Biopharma B decides to address broader solubility concerns first. Who gets to market first may surprise you.

 

Please complete the short form below to download this asset.

Looking for Solutions?

We can help.